Medical Research Council

Research council, England

Also known as MRC

United Kingdom

Follow this funder Website

Create a free account and its new calls come to you by email.

Open calls 0

Given in 2025 £585.2m

Typical grant £740k Middle half £386k to £1.4m

New grantees in 2025 13% first grant from this funder

Giving by year

£512.9m 2017 706

£589.5m 2018 707

£479.8m 2019 562

£484.4m 2020 606

£537.7m 2021 476

£774.0m 2022 668

£690.9m 2023 608

£578.4m 2024 516

£585.2m 2025 457

£263.1m 2026 190

13% of 2025 grantees were new to this funder 82% of grantees are funded again within three years

Amount and number of grants we hold records for in each year, which can be less than everything the funder gave. The current year is incomplete.

Where it gives

London 3,367 grants · typical £480k

South East 1,427 grants · typical £497k

Scotland 1,305 grants · typical £501k

East of England 960 grants · typical £544k

North West 860 grants · typical £451k

South West 614 grants · typical £395k

Yorkshire and The Humber 585 grants · typical £381k

West Midlands 532 grants · typical £392k

All years we hold. Grants with no recorded place are left out.

Latest grants made

University college London Next Gen HSC GT for IEI: Developing the next generation of haematopoietic stem cell gene therapies for inborn errors of immunity £460k 31 May 2027

University of cambridge Collaborative Union of Research Expertise (CURE): Investigating the oxytocin receptor mechanism in chronic visceral pain (CVP) suppression £257k 31 Dec 2026

Queen Mary University of London Identifying Small-molecule Activators Of Kinesin Using An AstraZeneca High-throughput Screen £256k 31 Dec 2026

Imperial college London Understanding how stress and negative affect exacerbate chronic neuropathic pain: Unlocking new therapeutic avenues (STRESSPAIN) £263k 30 Sep 2026

University of Birmingham Targeting vasculogenic mimicry to treat relapsed and metastatic rhabdomyosarcoma £2.5m 30 Sep 2026

University of sheffield Development of a human pluripotent stem cell-based therapy against Hirschsprung disease £2.3m 30 Sep 2026

King's college London Determining if mitochondrial complex I underlies neural dysfunction in schizophrenia £1.5m 30 Sep 2026

University of Birmingham MRC CoRE in Restorative Immunology £21.6m 30 Sep 2026

University college London Mapping the Storm: Defining Disease Trajectories in Adult HLH Using Longitudinal Clinical and Proteomic Biomarkers £418k 30 Sep 2026

University of Glasgow Translational Pain Discovery: BridGing MicE, Rat, aNd HUman Studies (GENUS) £263k 30 Sep 2026

Data: Contains public sector information licensed under the Open Government Licence v3.0 (UKRI Gateway to Research). (Open Government Licence v3.0); Contains public sector information licensed under the Open Government Licence v3.0 (UKRI Gateway to Research) (Open Government Licence v3.0)